Association of Biomarker Discrepancy and Treatment Decision, Disease Outcome in Recurrent/Metastatic Breast Cancer Patients

Association of Biomarker Discrepancy and Treatment Decision, Disease Outcome in Recurrent/Metastatic Breast Cancer Patients

BackgroundBiomarker discrepancy between primary and recurrent/metastatic breast cancer is well known, however its impact on prognosis and treatment after relapse is still unclear. Current study aims to evaluate biomarkers discrepancy between primary and recurrent/metastatic lesions as well as to inv...

Full description

Bibliographic Details
Main Authors: Yujie Lu, Yiwei Tong, Xiaosong Chen, Kunwei Shen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Oncology
Subjects:
breast cancer
biomarkers
treatment
recurrent
prognosis
discrepancy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.638619/full

Similar Items

Similar Items